Show simple item record

dc.contributor.authorPavlidis, Nicholasen
dc.contributor.authorPeccatori, Fedro A.en
dc.contributor.authorLofts, F.en
dc.contributor.authorGreco, F. A.en
dc.creatorPavlidis, Nicholasen
dc.creatorPeccatori, Fedro A.en
dc.creatorLofts, F.en
dc.creatorGreco, F. A.en
dc.date.accessioned2018-06-22T09:54:20Z
dc.date.available2018-06-22T09:54:20Z
dc.date.issued2015
dc.identifier.urihttps://gnosis.library.ucy.ac.cy/handle/7/42311
dc.description.abstractBackground: Cancer in pregnancy is a rare disease with breast cancer, cervical cancer, melanoma and Hodgkin's disease to be the most commonly diagnosed malignancies during gestation. Cancer of unknown primary (CUP) is a wellrecognized clinical disorder where the primary site can not be identified after a standard diagnostic approach. CUP in pregnancy has rarely been described. Materials and Methods: We searched MEDLINE and contacted cancer Centers in Europe, United States and Australia where patients with CUP or pregnant patients with cancer were diagnosed and treated. Results: Since 1976 we identified 18 pregnant women with CUP in a median gestational age of 34 weeks. Most of these patients were diagnosed with poorly-differentiated histology, had poor response to systemic treatment and a median maternal survival of 8 months. Seventy-two percent of mothers have died, while 80% of the newborns were alive and healthy. Almost one fourth of placentas examined showed metastatic disease. Conclusion: CUP during pregnancy is a very rare coexistence, usually has an aggressive disease with poor response to chemotherapy and a dismal prognosis. Both obstetricians and oncologists should be aware of this rare condition.en
dc.language.isoengen
dc.sourceAnticancer Researchen
dc.subjectReviewen
dc.subjectCyclophosphamideen
dc.subjectDoxorubicinen
dc.subjectHumanen
dc.subjectNeoplasmsen
dc.subjectHumansen
dc.subjectCancer patienten
dc.subjectFemaleen
dc.subjectCancer survivalen
dc.subjectClinical articleen
dc.subjectGemcitabineen
dc.subjectTaxane derivativeen
dc.subjectHuman tissueen
dc.subjectPlatinumen
dc.subjectPrognosisen
dc.subjectCytoreductive surgeryen
dc.subjectSurvival rateen
dc.subjectTreatment outcomeen
dc.subjectMetastasisen
dc.subjectNeoplasticen
dc.subjectPregnancyen
dc.subjectPregnancy complicationsen
dc.subjectPregnant womanen
dc.subjectSystemic therapyen
dc.subjectCancer prognosisen
dc.subjectBone metastasisen
dc.subjectTrastuzumaben
dc.subjectMortalityen
dc.subjectHistopathologyen
dc.subjectLaparotomyen
dc.subjectCancer centeren
dc.subjectLymph node metastasisen
dc.subjectMedlineen
dc.subjectAdrenal metastasisen
dc.subjectGestational ageen
dc.subjectLiver metastasisen
dc.subjectLung metastasisen
dc.subjectTreatmenten
dc.subjectArticleen
dc.subjectCancer of unknown primary siteen
dc.subjectUnknown primaryen
dc.subjectCancer of unknown primaryen
dc.subjectBreast metastasisen
dc.subjectPeritoneum metastasisen
dc.subjectPlacentaen
dc.subjectBladder metastasisen
dc.subjectBone marrow metastasisen
dc.subjectCentral nervous system metastasisen
dc.subjectDiaphragm metastasisen
dc.subjectHeart metastasisen
dc.subjectIntestine metastasisen
dc.subjectLive birthen
dc.subjectMuscle metastasisen
dc.subjectPelvis metastasisen
dc.subjectPlacental in-vasionen
dc.subjectSpleen metastasisen
dc.subjectSurgical techniqueen
dc.subjectVemurafeniben
dc.titleCancer of unknown primary during pregnancy: An exceptionally rare coexistenceen
dc.typeinfo:eu-repo/semantics/article
dc.description.volume35
dc.description.issue1
dc.description.startingpage575
dc.description.endingpage580
dc.author.facultyΙατρική Σχολή / Medical School
dc.author.departmentΙατρική Σχολή / Medical School
dc.type.uhtypeArticleen
dc.contributor.orcidPavlidis, Nicholas [0000-0002-2195-9961]
dc.contributor.orcidPeccatori, Fedro A. [0000-0001-8227-8740]
dc.gnosis.orcid0000-0002-2195-9961
dc.gnosis.orcid0000-0001-8227-8740


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record